Clinical Trials Browser

OTHER × Fallopian Tube Neoplasms × IT-101 × Clear all

NCT01652079 2018-07-02

CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms